98-14463. Good Clinical Practices In Investigational Product Research Meeting  

  • [Federal Register Volume 63, Number 105 (Tuesday, June 2, 1998)]
    [Notices]
    [Page 30001]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 98-14463]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    
    
    Good Clinical Practices In Investigational Product Research 
    Meeting
    
    AGENCY:  Food and Drug Administration, HHS.
    
    ACTION:  Notice of meeting.
    
    -----------------------------------------------------------------------
    
        The Food and Drug Administration (FDA) (Office of Regulatory 
    Affairs, New Orleans District Office) is announcing the following 
    meeting: ``Good Clinical Practices In Investigational Product 
    Research.'' The topics to be discussed are FDA regulatory requirements 
    for the conduct of investigational product research and practical 
    issues, such as, how to prepare for a data audit, what to expect during 
    an investigation, and how to get current information from FDA. The 
    purpose of this meeting is to promote and encourage open dialogue 
    between FDA and professionals involved in investigational product 
    research: Physicians, researchers, research coordinators, nurses, 
    allied health professionals, and any other interested parties.
        Date and Time: The meeting will be held on Friday, July 17, 1998; 
    registration from 7:45 a.m. to 8:30 a.m.; meeting from 8:30 a.m. to 5 
    p.m.
        Location: The meeting will be held at the Louisiana State 
    University Medical Center, Medical Education Bldg., Lecture Room A, 
    1901 Perdido, New Orleans, LA 70112.
        Contact: Rebecca A. Asente, Food and Drug Administration, New 
    Orleans District Office (HFR-SE440), 4298 Elysian Fields Ave., New 
    Orleans, LA 70122, 504-589-6344, ext. 158, FAX 504-589-6360.
        Registration: Send registration information (including name, title, 
    firm name, address, telephone, and fax number) to the contact person by 
    Friday, July 10, 1998. There is no registration fee for this meeting. 
    Attendance will be limited to the first 200 applicants, therefore, 
    interested parties are encouraged to register early. Priority will be 
    given to those individuals located in Louisiana and Mississippi. 
    Individuals located outside these States may register to attend the 
    meeting and will be accepted if space is available.
        If you need special accommodations due to a disability, please 
    contact Rebecca A. Asente at least 7 days in advance.
    
        Dated: May 21, 1998.
    William K. Hubbard,
    Associate Commissioner for Policy Coordination.
    [FR Doc. 98-14463 Filed 6-1-98; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Published:
06/02/1998
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice of meeting.
Document Number:
98-14463
Pages:
30001-30001 (1 pages)
PDF File:
98-14463.pdf